PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
30-Oct-2019 MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice Capo Therapeutics, Inc
30-Oct-2019 Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis Top line data to be presented at 2019 Scientific Sessions of American Heart Association Sanifit
30-Oct-2019 Dupixent® (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis Regeneron
30-Oct-2019 SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor B3C newswire
30-Oct-2019 Galmed Pharmaceuticals to Report Third Quarter 2019 Financial Results and Provide Business Update on Wednesday, November 6 Galmed Pharmaceuticals Ltd.
30-Oct-2019 ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2019 Financial Results ANI Pharmaceuticals, Inc.
30-Oct-2019 Registration opens for SMi’s AI in Drug Discovery Conference 2020 SMi Group
30-Oct-2019 Medios AG continues dynamic growth in third quarter - Forecast for 2019 financial year confirmed Medios AG
30-Oct-2019 LEO PHARMA ENTERS INTO OPTION AGREEMENT WITH UBIQUIGENT FOR ACCESS TO NOVEL COMPOUNDS Ubiquigent
30-Oct-2019 TSI Reports Enrollment of First 10 Patients in its Phase 2 Ischemic Stroke Clinical Trial and Completion of its Phase 2 Study Protocol in Myocardial Infarction B3C newswire
30-Oct-2019 AEVIS VICTORIA SA: Acquisition of the building of Clinique Nescens Paris Spontini AEVIS VICTORIA SA
30-Oct-2019 Danaher Announces Pricing Of Senior Notes Offering Danaher Corporation
29-Oct-2019 MorphoSys AG Reports Third Quarter 2019 Financial Results (news with additional features) MorphoSys AG
29-Oct-2019 MorphoSys AG: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone (news with additional features) MorphoSys AG
29-Oct-2019 MorphoSys AG: Ad hoc: Primary Endpoint met in Real-World Data Study Demonstrating Clinical Superiority of the Combination of Tafasitamab and Lenalidomide compared to Lenalidomide alone MorphoSys AG
29-Oct-2019 PharmiWeb To Launch In Australia PharmiWeb.Jobs
29-Oct-2019 Upperton continues to invest in key equipment to support expansion of its solid dosage form capabilities and CDMO services Upperton Pharma Solutions
29-Oct-2019 European CNS specialist Neuraxpharm enters booming CBD market Neuraxpharm Group
29-Oct-2019 Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019 (news with additional features) Expedeon AG
29-Oct-2019 Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019 Expedeon AG